14 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

VITROS CHEMISTRY PRODUCTS BUN/UREA SLIDES AND VITROS CHEMISTRY PRODUCTS CALIBRATOR KIT 1

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

Henry Schein

FDA UDI
HENRY SCHEIN, INC.·10304040059880·Premium Needles 27Ga Long

SoundBite® Active Wire 14P

FDA UDI
Soundbite Medical Solutions Inc·17540265101024·The SoundBite® Active Wire 14P which is part o...

SoundBite® Active Wire 14P

FDA UDI
Soundbite Medical Solutions Inc·10754026501023·The SoundBite® Active Wire 14P which is part o...

PREMIUM PLUS CEEA

FDA Adverse Event
Malfunction ·US SURGICAL PUERTO RICO·Product code GDW·April 19, 2018

MODIFICATION TO ONYX, FINGER CLIP PULSE OXIMETER, MODEL 9500

FDA 510(k)
FDA Class 2 ·Cardiovascular

DRX HBA1C - FOR PRESCRIPTION HOME USE

FDA 510(k)
FDA Class 2 ·Hematology

7900

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS GMBH·Product code JAA·February 12, 2013

FREESTYLE LITE

FDA Adverse Event
Injury ·Product code NBW·February 25, 2011

FREESTYLE FREEDOM

FDA Adverse Event
Malfunction ·ABBOTT DIABETES CARE INC, USA·Product code LFR·February 19, 2008

NIBP CUFFS

FDA Adverse Event
Injury ·PHILIPS MEDIZIN SYSTEME BÖBLINGEN GMBH·Product code OED·August 8, 2025

bk5000 Ultrasound System w/battery; Model No. 2300-61; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024